Today's Headlines in Indonesia

The Today's Headlines section of Indonesia Investments is a daily updated section which contains the latest information with regard to topics that are currently causing headlines in Indonesia's media. Most of our headlines will cover political, economic and social matters. As a consequence of their recent nature, these topics may not have crystallized fully yet and can, therefore, lack a profound analysis. For publications with a more in-depth understanding of subjects, we refer you to our News, Financial or Business columns.

  • Stock Market Update: Why Do Indonesian Stocks Hit a Record High?

    The benchmark stock index of Indonesia (Jakarta Composite Index, abbreviated JCI or IHSG) posted a series of consecutive record high closes during the past week, primarily on the central bank’s (Bank Indonesia) decision to cut its key interest rate (BI rate) by 25 basis points to 7.50 percent, investors’ positive outlook on Indonesian companies’ corporate earnings in 2015 and expectation that the Eurozone’s quantitative easing program will offset the negative impact of monetary tightening in the USA.

    Read more ›

  • Mining News Update: Indonesia May Delay Full Mineral Ore Export Ban

    The Indonesian Ministry of Energy and Mineral Resources signaled that the government may (again) decide to postpone full implementation of its ban on exports of raw mineral ores and concentrates as the country still lacks sufficient smelting capacity to produce value-added mining products. Through this export ban, stipulated by the 2009 Mining Law, the Indonesian government aims to enhance revenue generation in the country’s natural resources sector by forcing miners to produce and export value-added products instead of raw materials.

    Read more ›

  • Shares of Indonesia’s Kalbe Farma Hurt by Fatal Medicine Scandal

    Shares of Kalbe Farma, Indonesia’s largest pharmaceutical company, have been under pressure over the past couple of days due to the deaths of two hospital patients after they had taken a medicine manufactured by Kalbe Farma. According to the Indonesian Pharmacy Association (GP Farmasi Indonesia) Buvanest Spinal, an anesthetic, was wrongly packaged and hence did not contain bupivacaine but instead tranexamic acid, which aims to stop or reduce heavy bleeding (usually used during surgery).

    Read more ›

  • Markets Feel Impact of Bank Indonesia’s Interest Rate Cut

    One day after the surprise interest rate cut by Indonesia’s central bank, Indonesian stocks surge to a new record level led by interest rate sensitive stocks (such as financial institutions, construction firms and property firms) while the rupiah and government bonds are weakening. Yesterday (17/02), Bank Indonesia shocked markets by lowering its key interest rate (BI rate) and deposit facility rate (Fasbi) by 25 basis points, each, to 7.50 percent and 5.50 percent, respectively. Easing monetary policy is back in fashion among the region’s central banks.

    Read more ›

Today's Headlines